Allergan Inc. (AGN) to Acquire Privately Held Dermatologic Company, Vicept Therapeutics Incorporated in Deal Worth Up to $275 Million
7/19/2011 7:20:37 AM
More...
|
Vicept Therapeutics Incorporated Announces Positive Results from a Second Phase II Study of V-101 for the Treatment of Type I Rosacea (Erythematotelangiectatic Rosacea)
4/19/2011 10:37:11 AM
More...
|
Vicept Therapeutics Incorporated Announces Positive Phase II Data of V-101 for the Treatment of Type I Rosacea (Erythematotelangiectatic Rosacea)
1/10/2011 9:11:53 AM
More...
|
Vicept Therapeutics Incorporated Announces Positive Clinical Study Results of V-101 for the Treatment of the Erythema of Rosacea
8/5/2010 10:32:05 AM
More...
|
Vicept Therapeutics Incorporated Secures $10 Million to Complete Series A Funding
6/30/2010 6:40:38 AM
More...
|